Icosavax Announces Topline Interim Phase 1/2 Results for IVX-411 Against SARS-CoV-2
– Immunologic response observed in both SARS-CoV-2 naive and previously vaccinated subjects, but lower than…
– Immunologic response observed in both SARS-CoV-2 naive and previously vaccinated subjects, but lower than…
MORF-057, an oral α4β7 integrin inhibitor candidate, holds potential for treating inflammatory bowel diseases Phase…
Virtual Bio-Europe Spring 2022 Kempen Life Sciences Conference Asebio Investor Day MADRID, Spain and CAMBRIDGE,…
Sub-analysis of the Phase 2b CONTROL study in congenital ichthyosis demonstrates treatment success with TMB-001…
New 3-D process designed to increase yield and improve operating efficiency for rapid and scalable…
Pooled analysis of DERMIS-1 and DERMIS-2 demonstrated significantly more roflumilast-treated patients achieved Investigator Global Assessment…
Previously reported data demonstrated that roflumilast foam provided statistically significant improvement in disease severity and…
Reached new record market share overall adult use market share of 2.06% in February 2022,…
LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
OXFORD, United Kingdom, March 25, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) today announced…
Global Phase 2b trial for eblasakimab in moderate-to-severe atopic dermatitis (AD) underway with topline data…
Approval of 36-month shelf life encompasses all ASCENIV & BIVIGAM vial sizes, production scales, as…
BALA CYNWYD, Pa., March 25, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
This clinical trial, the first-ever oral immunotherapy for patients with mild-to-moderately active Crohn’s Disease, is…
RESEARCH TRIANGLE PARK, N.C., March 25, 2022 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC;…
Gotchiverse launching March 31, 2022 Singapore, Singapore–(Newsfile Corp. – March 25, 2022) – Pixelcraft Studios’…
Calgary, Alberta–(Newsfile Corp. – March 25, 2022) – Sprout AI Inc. (CSE: BYFM) (OTCQB: BYFMF)…
TOKYO, Mar 25, 2022 – (JCN Newswire) – JTOWER Inc. (“JTOWER”) and NTT DOCOMO, INC….
Sydney, Australia, Mar 25, 2022 – (ACN Newswire) – WarSindia, the first Esports-to-earn NFT game…
Seoul, Korea, Mar 25, 2022 – (ACN Newswire) – GONGGANTECH is proud to announce the…